Fig. 6From: The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapyRelationship between early tumor shrinkage (ETS) and the alpha-fetoprotein (AFP) response categories, in patients treated with immunotherapy for hepatocellular cancer. mRECIST: modified response evaluation criteria in solid tumorsBack to article page